09:40 EDT BioXcel Therapeutics trading resumes
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BTAI:
- BioXcel (NASDAQ: BTAI) Tanks on Plans of Layoffs, Strategic Reorganization
- BioXcel Therapeutics expects cash to last through mid-2024
- BioXcel Therapeutics to reduce workforce from 190 to 80 employees
- BioXcel Therapeutics reports Q2 EPS ($1.83), consensus ($1.75)
- BioXcel Therapeutics Reports Second Quarter 2023 Financial Results and Announces Strategic Reprioritization